Plain-English translation of NCT05116930 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether and — two medications given intravenously — can help treat the severe headaches that sometimes develop after an epidural needle accidentally punctures the spinal membrane during labor. These headaches are debilitating, especially for new mothers who need to care for their newborns, and many women currently require a more invasive procedure called an epidural blood patch to find relief. This trial is exploring whether the medication might prevent that need or ease symptoms while the headache naturally resolves.
About half of women who experience an accidental dural puncture during labor develop a severe headache within a few days—one that is worsened by sitting or standing up. While most headaches eventually go away on their own, the waiting period is extremely difficult for postpartum women juggling newborn care. The standard treatment involves a procedure with its own risks and contraindications, so researchers are testing whether this medication could offer a gentler alternative.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive an IV infusion of the study medications at the hospital or clinic. The research team would monitor your symptoms and pain levels before and after the treatment to see whether the medication helps reduce your headache. You would likely complete pain questionnaires and symptom assessments over a short period of time to track how you're doing.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States